Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GLGC Gene Logic -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (128)	4/11/2000 12:56:00 PM
From: Linda Pearson	Respond to of 360

marketwatch.newsalert.com <<<Gene Logic Sells GeneExpress(TM) Module to NeuralStem BioPharmaceuticals - Gains Access to Neural Stem Cells for Inclusion In the GeneExpress Database - PR Newswire - April 11, 2000 09:47 GAITHERSBURG, Md., April 11 /PRNewswire/ -- Gene Logic Inc. (Nasdaq: GLGC), a leading provider of genomic information, today announced that NeuralStem BioPharmaceuticals, Ltd. has purchased a module of the GeneExpress(TM) database which NeuralStem will utilize for its drug discovery and development programs in several CNS disease areas, including neurodegenerative and psychiatric disorders and stroke. The GeneExpress database is a massive reference set of gene expression information across a broad range of normal and diseased human tissues, experimental animals and disease models and cell lines. NeuralStem becomes the fourth commercial customer for the product since release of the first commercial version of the database in November 1999. Financial terms of the agreement were not disclosed.>>>